방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 류마티스 관절염 삶의 질 척도× | EORTC QLQ-C30× | |
|---|---|---|
| 분야 | 건강 결과 | 건강 결과 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1997 | 1993 |
| 창시자≠ | Stephen P. McKenna et al. | Nico Aaronson et al. |
| 유형 | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| 원전≠ | de Jong, Z., van der Heijde, D. M., McKenna, S. P., & Whalley, D. (2000). The Rheumatoid Arthritis Quality of Life Scale (RAQoL): Final Dutch version allows three methods of data handling. Arthritis & Rheumatism, 13(6), 408-413. link ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 별칭 | RA-QoL, Rheumatoid Arthritis QoL, RAQoL | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 관련≠ | 4 | 5 |
| 요약≠ | The RA-QoL is a disease-specific quality of life measure for rheumatoid arthritis (RA). Developed by Stephen McKenna and colleagues in 1997, this 30-item questionnaire quantifies how RA affects daily activities, emotional well-being, functional independence, and social engagement. It is a standard outcome measure in RA research and clinical trials, capturing dimensions beyond joint inflammation and functional disability. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGate데이터셋 ↗ |
|
|